Clinical Trials Logo

Clinical Trial Summary

Retinal artery occlusions (RAO) cause deterioration in visual acuity and visual fields. In computational fluid dynamics (CFD) studies [1] 10% of ascending emboli caused RAO, the residual 90% embolized into the cerebral arteries. As only 20% of patients with RAO had a history of stroke, there is a discrepancy between CFD-studies and clinical observations. Mead et al. [2] postulated small emboli being washed into the cerebral arteries without causing clinical symptoms of stroke, whereas similar emboli being washed into the ophthalmic artery would cause RAO.

There is a discrepancy between CFD-study results and clinical observations in RAO patients, indicating that there could be a high number of RAO-patients having had cerebral ischemies without symptoms of stroke (as postulated by Mead et al.[2]).

Purpose of the present study is to evaluate hemodynamic pathological changes at the ophthalmic artery origin in patients with RAO detected with an already existing CFD-model


Clinical Trial Description

Retinal artery occlusions (RAO) cause deterioration in visual acuity and visual fields. Emboli from plaques of the carotid artery, aortic arch or vegetations of the cardiac valves are the main reasons for RAO. In computational fluid dynamics (CFD) studies [1] 10% of ascending emboli caused RAO, the residual 90% embolized into the cerebral arteries. As only 20% of patients with RAO had a history of stroke, there is a discrepancy between CFD-studies and clinical observations. Mead et al. [2] postulated small emboli being washed into the cerebral arteries without causing clinical symptoms of stroke, whereas similar emboli being washed into the ophthalmic artery would cause RAO. Hayreh et al. [3] reported plaques of the carotid artery to be the main reason for emboli causing RAO.

There is a discrepancy between CFD-study results and clinical observations in RAO patients, indicating that there could be a high number of RAO-patients having had cerebral ischemies without symptoms of stroke (as postulated by Mead et al.[2]). A recently published report showed ischemic cerebral lesions in 38% of patients with RAO without neurological symptoms [4]. The fact, that the 3-year risk of patients with RAO to develop stroke is doubled [5], underlines further associations between RAO and stroke.

Purpose of the present study is to evaluate hemodynamic pathological changes at the ophthalmic artery origin in patients with RAO detected with an already existing CFD-model

References (detailed references are provided in the reference section) :

[1] Leisser et al., [2] Mead et al., [3] Hayreh et al., [4] Lee et al., [5] Chang et al. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02679716
Study type Interventional
Source Vienna Institute for Research in Ocular Surgery
Contact
Status Completed
Phase N/A
Start date December 2014
Completion date July 31, 2018

See also
  Status Clinical Trial Phase
Completed NCT02898480 - Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning N/A
Terminated NCT00637468 - EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye Phase 3
Recruiting NCT05130385 - High Resolution Optical Coherence Tomography
Completed NCT03753893 - Ocular Manifestations in Rheumatic Diseases
Recruiting NCT03090087 - The Effect of A2A Adrenoceptor Stimulation on the Diameter of Retinal Arterioles During Hypoxia in Vivo Phase 2
Completed NCT03357146 - Optical Coherence Tomography Angiography Examinations in Chronic Retinal Artery Occlusion
Completed NCT00804102 - Transcorneal Electrical Stimulation Therapy for Retinal Disease N/A
Terminated NCT01717937 - Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging N/A
Recruiting NCT03313817 - Pre and Post-arterial Recanalization Imaging of Central Retinal Artery Occlusions (CRAO)
Completed NCT04723160 - Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph
Completed NCT02806830 - Ocular Discomfort Assessment After Intravitreal Injections N/A